Search results
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
Morningstar· 1 day agoManufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval CAMBRIDGE, MA / ACCESSWIRE ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoSo far, three people in the U.S. have been sickened by the bird flu following contact with infected...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WUSF 89.7· 12 hours agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 1 day agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 5 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 5 days agoThe RSV vaccine will now be reviewed at the CDC's Advisory Committee on Immunization Practices...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 21 hours agoThe Food and Drug Administration on Friday expanded the approval of GSK's respiratory syncytial...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 5 days agoIn the study, Moderna and Merck combined their cancer treatments—Moderna’s experimental cancer vaccine and Merck’s approved checkpoint ...
FDA panel recommends new COVID-19 vaccine formula for fall
UPI· 2 days agoDr. Peter Marks, who oversees the FDA's vaccine division, urged the committee to consider...